As expected, xenograft tumors exhibited the typical histology of CRC adenocarcinomas, expressing the proliferation marker KI67 and partially also differentiation markers such as CDX2, particularly following KAT2A knockdown. The gene discussed is CDX2; the disease is colorectal carcinoma.